Microbio Co., Ltd. applies symbiotic fermentation technology to develop botanical drug. The Company's products include clinically proven botanical drugs, pharmaceutically active ingredients, and nutrient supplements.

Announces The Information About The 2nd Online
Investor'S Conference Of 2024.

Announcement On Behalf Of Major Subsidiary Cotton
Field Organic Co.,Ltd. Regarding Acquisition Of
Right-Of-Use Asset For Real Estate From Related Party

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Microbio Co Ltd (4128 TT)

Announces The Information About The 2nd Online Investor'S Conference Of 2024.

Announcement On Behalf Of Major Subsidiary Cotton Field Organic Co.,Ltd. Regarding Acquisition Of Right-Of-Use Asset For Real Estate From Related Party

Announcement Of The Disposal Of Right-Of-Use Asset For Real Estate To Related Party

Announcement Of Year 2024q3 Consolidated Financial Reports Were Approved By The Bod

Announcement Of The Date Of The Company'S Board Of Directors Meeting For The Third Quarter Of 2024 Consolidated Financial Reports

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)